Monday, 25 June 2018

Lilly's Jardiance meets main goal of two diabetes trials

(Reuters) - Eli Lilly & Co said on Monday that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing it in patients with type 1 diabetes.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)